Skip to main content
Clinical Trials/ISRCTN28639298
ISRCTN28639298
Active, not recruiting
未知

Identification of disease susceptibility genes associated with development and clinical characteristics of primary inflammatory muscle diseases, polymyositis (PM), dermatomyositis (DM) and inclusion body myositis (IBM)

Manchester University (UK)0 sites1,947 target enrollmentSeptember 21, 2010

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Manchester University (UK)
Enrollment
1947
Status
Active, not recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 21, 2010
End Date
December 31, 2030
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Manchester University (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Skin lesions of (DM):
  • 1\.1\. Heliotrope rash (violaceous rash and on upper eyelids)
  • 1\.2\. Gottron?s sign (violaceous keratotic macules on extensor aspect of finger joints)
  • 1\.3\. Violaceous slightly raised rash over elbows/knees
  • 2\. Proximal muscle weakness (PM, DM and IBM)
  • 3\. Elevated plasma muscle enzymes
  • 4\. Myalgia, at rest or with contraction
  • 5\. Myopathic changes on electromyogram (EMG)
  • 6\. Anti Jo1 Ab
  • 7\. Nondestructive arthritis

Exclusion Criteria

  • 1\. Below the age of 18 years
  • 2\. Myositis secondary to:
  • 2\.1\. Alcohol or drug abuse
  • 2\.2\. Non\-abusive drug ingestion (e.g with statins, fibrates etc), or
  • 2\.3\. A recent viral illnesses
  • 3\. Unable to give consent due to diminished mental capacity or inability to speak sufficient English
  • 4\. Unwilling to give blood samples

Outcomes

Primary Outcomes

Not specified

Similar Trials